Safety and tolerability of moxifloxacin for the treatment of disseminated BCGitis in children
Background and objective: Disseminated BCGitis is a rare but serious complication of BCG vaccine in patients with underlying primary immunodeficiency. Fluoroquinolone antibiotics containing antimycobacterial regimen have been considered in the treatment of disseminated BCGitis, but there are limited...
Main Authors: | Mohammed Alsuhaibani, Ghada Felimban, Mohamed Shoukri, Abdullah Alosaimi, Abdullah Almohaizeie, Sami AlHajjar |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | International Journal of Pediatrics and Adolescent Medicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352646718301996 |
Similar Items
-
BCGitis in children
by: I. Ladeira, et al.
Published: (2014-05-01) -
Erratum to âBCGitis in childrenâ
by: I. Ladeira, et al.
Published: (2016-11-01) -
BCGitis as the primary manifestation of chronic granulomatous disease
by: Nastaran Khalili, et al.
Published: (2021-01-01) -
Moxifloxacin: safety profile
by: A. I. Sinopalnikov
Published: (2013-12-01) -
BCGitis: A rare complication after intravesical BCG therapy
by: Maria João Oliveira, et al.
Published: (2015-10-01)